Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated May 15, 2015 (11 years ago)

MD-Gastroview

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: incorrect or missing lot number and/or expiration date

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

MD-Gastroview (Diatrizoate Meglumine and Diatrizoate Sodium Solution USP); 37% Organically Bound Iodine For Gastrointestinal Radiography; Oral or rectal use only; Rx only; 30 mL; Single-Unit Container; ; Mallinckrodt Inc., St. Louis, MO 63042. NDC 0019-4816-04

Affected NDC 0019-4816-04

Compare with the code on your package — it is the most precise check available.

Drug: Iodine

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Md Gastroview
diatrizoate meglumine and diatrizoate sodium
NDC 00019-4816
DIATRIZOATE MEGLUMINE 600 mg/mL; DIATRIZOATE SODIUM 100 mg/mL Solution
Oral|rectal
Liebel-Flarsheim Company LLC Rx
Recalling firm
Mallinckrodt, Inc.
NDC code
0019-4816-04
Origin
MO, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1132-2015 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Iodine recalls

See all
Class II · Moderate risk

BD PurPrep

Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-014-42 D-0644-2026
Class II · Moderate risk

BD PurPrep

Lack of assurance of Sterility: potential product contamination

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-014-41 D-0518-2026

Other recalls by Mallinckrodt, Inc.

All 2015 recalls
Class III · Low risk

Thallous Chloride Tl 201 Injection

Labeling: Correct Labeled Product Miscart/Mispack: labels on outer containers do not match labels on vials (the correct label)

Terminated Labeling / mix-up Mallinckrodt Inc D-1692-2012